|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Statements of Operations: | |||||
| Revenue | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Marketing and sales | |||||
| Research and development | |||||
| General and administrative | |||||
| Goodwill impairment | |||||
| Total goodwill impairment | |||||
| Restructuring and transformation costs | |||||
| Costs related to disposal and exit activities | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income (expense), net | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Shares used to compute net income per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Other Comprehensive Income, net of tax | |||||
| Foreign currency translation adjustments | |||||
| Net unrealized gains on investments in securities | |||||
| Comprehensive income | |||||
Loading...